GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about General Updates
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GlaxoSmithKline Pharmaceuticals has informed the exchanges that it has sent letters to shareholders whose email IDs are not registered with the company or depository participants, sharing a weblink to access the Annual Report for the financial year ended 31 March 2025. The web-link to the report is hosted on the company's investor page. The letter also reminds shareholders to update their PAN, KYC (address, email, mobile, bank details), and nomination information with their depository participant or the registrar (Kfin Technologies). The company highlighted that dividends and other payments to folios with incomplete PAN/KYC will only be processed electronically after details are updated. A dedicated senior citizens investor cell run by Kfin was also mentioned for grievance support.
This is a routine compliance filing with no material impact on the stock. Shareholders without updated KYC details should take action to ensure they receive dividends and other communications without delay.